Molecules (Jan 2016)

Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity

  • Teshome Aboye,
  • Christopher J. Meeks,
  • Subhabrata Majumder,
  • Alexander Shekhtman,
  • Kathleen Rodgers,
  • Julio A. Camarero

DOI
https://doi.org/10.3390/molecules21020152
Journal volume & issue
Vol. 21, no. 2
p. 152

Abstract

Read online

We report for the first time the design and synthesis of a novel cyclotide able to activate the unique receptor of angiotensin (1-7) (AT1-7), the MAS1 receptor. This was accomplished by grafting an AT1-7 peptide analog onto loop 6 of cyclotide MCoTI-I using isopeptide bonds to preserve the α-amino and C-terminal carboxylate groups of AT1-7, which are required for activity. The resulting cyclotide construct was able to adopt a cyclotide-like conformation and showed similar activity to that of AT1-7. This cyclotide also showed high stability in human serum thereby providing a promising lead compound for the design of a novel type of peptide-based in the treatment of cancer and myocardial infarction.

Keywords